5th Annual Childhood Cancer Summit Featuring NIH Director Francis Collins

On Friday, September 19, Dr. Francis Collins, the Director of the National Institutes of Health (NIH) was the keynote speaker at the 5th Annual Childhood Cancer Summit: "Pediatric Cancer: Major Advances, Major Challenges".
5th Annual Childhood Cancer Summit Featuring NIH Director Francis Collins feature image

VIDEO: Welcome to the Childhood Cancer Caucus Website

Rep. McCaul and Rep. Van Hollen: Welcome to the new website of the Congressional Childhood Cancer Caucus.
 Welcome to the Childhood Cancer Caucus Website feature image

McCaul-Butterfield 'Creating Hope Act' Now Law

Incentivizes Drug Companies to Develop New Treatments for Children with Rare Pediatric Diseases
McCaul-Butterfield 'Creating Hope Act' Now Law feature image

VIDEO: Dennis Quaid Supports the Creating Hope Act

Actor, Dennis Quaid, endorses The Creating Hope Act, which will provide market incentives for pharmaceutical companies to develop childhood cancer and other rare pediatric disease drugs.
 Dennis Quaid Supports the Creating Hope Act feature image

Latest News

Creating Hope Act Sponsors React to FDA Approval of Pediatric Cancer Treatment

Mar 13, 2015 Press Release

The sponsors of the Creating Hope Act applaud the approval of the first drug ever to treat high-risk neuroblastoma and call for the law to be made permanent.

Caucus Applauds NCI for Naming Pediatric Oncologist to Council of Research Advocates

Sep 30, 2014 Press Release

The Childhood Cancer Caucus applauds Dr. Harold Varmus, the Director of the National Cancer Institute (NCI), for announcing the appointment of Dr. Greg Aune, a pediatric hematologist-oncologist from The University of Texas Health Science Center at San Antonio, to NCI's Council of Research Advocates.

FDA Awards $1.6 Million Grant to Stimulate Treatment for Pediatric Low Grade Gliomas

Sep 30, 2014 Press Release

On September 30th, the U.S. Food and Drug Administration announced it has awarded 15 grants totaling more than $19 million to boost the development of medical device, drug, and biological products for patients with rare diseases, with at least a quarter of the funding going to studies focused solely on pediatrics. $1.6 million will go toward a Phase 2 Study of Poly-ICLC for the Treatment of Pediatric Low Grade Gliomas, the most common type of brain tumor in children.

NCI Announces a Pediatric MATCH Trial for Childhood Cancer

Sep 19, 2014 Press Release

On September 19, Dr. Francis Collins, the Director of the National Institutes of Health (NIH), announced a new pediatric trial for children with cancer. Sponsored by the National Cancer Institute (NCI), the Molecular Analysis for Therapy Choice Program (MATCH) trial will enroll children with advanced cancers that have progressed on standard therapy.

5th Annual Childhood Cancer Summit Photos and Video